Intelligo

Private limited company · Overhalla

PHARMAQ AS

ActiveManufacture of pharmaceutical preparations (21.200)

Founded
27 May 2004
Employees
297
Chief executive
Bernt Martinsen
Business address
Skogmo Industriområde, Industrivegen 50, 7863 Overhalla

The life line 2004–2026

Operating revenue per year, with recorded events above. As a table

Operating revenue 2025: NOK 2.6bn.

  1. Chair took office§ 07
  2. Managing director took office§ 07
  3. Founded§ 16

Sources: the Register of Company Accounts (company accounts), fetched 15 Nov 2026; the Brønnøysund Register Centre. Each event has the colour of the section it is in.

In brief

PHARMAQ AS is a private limited company in Overhalla, founded in 2004, in the industry manufacture of pharmaceutical preparations. The chief executive is Bernt Martinsen, and the chair of the board is Ben Backmann. In 2025 the company had NOK 2.6bn in operating revenue and a net profit of NOK 1.5bn. The largest owner is PHARMAQ HOLDING AS with 100.0%.

Put together by Intelligo from the sections below; each figure stands with its source where it belongs.

Overview

§ 01 Latest changes

4 changes, latest 13 Nov 2026

  • Number of employees 298 → 297
  • Number of employees 297 → 298
  • Number of employees 300 → 297
  • Annual accounts filed 2024 → 2025

Source: the Brønnøysund Register Centre and Intelligo's own observations, fetched 15 Nov 2026 · All events →

Overview

§ 02 Worth knowing

1 point

  • OKEquity ratio 89.6%, above the industry median

Assumed: derived by Intelligo by fixed rules, not a credit rating. How we calculate

Overview

§ 03 Key figures

Revenue NOK 2.6bn in 2025

Revenue

NOK 2.6bn

+29.2% from 2024

20232025

Operating profit

NOK 1.7bn

+50.9% from 2024

20232025

Net profit

NOK 1.5bn

+53.7% from 2024

20232025

Equity

NOK 5.9bn

+32.7% from 2024

20232025

Source: the Register of Company Accounts, read 15 Nov 2026 · The full accounts →

Finances

§ 04 Where the money comes from and goes

Financial year 2025

Of every krone of operating revenue in 2025:

  • Wages and social costs 15%
  • Depreciation 2%
  • Other operating costs 8%
  • Not specified in the source 8%
  • Left as operating result 67%

Of the net profit for 2025, NOK 1.5bn stayed in the company. The rest, NOK 1k, is an assumed dividend.

The assumed dividend is derived by Intelligo from the change in equity, not stated by the source. Source: the Register of Company Accounts via areg.no, read 15 Nov 2026

Finances

§ 05 Financial health

Equity ratio 89.6%

RevenueNOK 2.6bn Operating margin66.9% Equity ratio89.6% Revenue growth+29.2%
  • PHARMAQ AS, 2025
  • Industry median, assumed: NOK 31.9m · 7.0% · 50.3% · +3.9%

Equity NOK 5.9bn90% of the assets (NOK 6.6bn)

Source: the Register of Company Accounts, read 15 Nov 2026. The median is derived by Intelligo from 28 companies in 21.200 Manufacture of pharmaceutical preparations, not stated by the source.

Finances

§ 06 Accounts

22 years, latest 2025

NOK 1,0002023–25202520242023
Operating revenue2,606,6272,017,4872,179,986
Operating profit1,744,3991,156,0401,321,191
Profit before tax1,876,3841,227,3651,381,036
Net profit1,458,651949,0031,078,014
Total assets6,615,7704,993,0923,995,280
Equity5,924,4584,465,8083,521,526
Liabilities691,312527,285473,754

Source: the Register of Company Accounts, read 15 Nov 2026 · All 22 years →

Management and ownership

§ 07 Officers

8 officers now

The board: 4 members

Source: the Brønnøysund Register Centre, read 22 Oct 2026 · All 8 roles, former ones too →

Management and ownership

§ 08 Signature, procuration and authorisations

The board has no authorisation in force now.

Source: authorisations from the announcements of the Register of Business Enterprises, read 2 Nov 2026

Management and ownership

§ 09 Owners

1 shareholder · largest 100.0%

OwnerShare
PHARMAQ HOLDING AS
100.0%

Source: the Tax Administration's Register of Shareholders as of 31 December 2020, read 31 Jul 2026 · All 1 owners →

Management and ownership

§ 10 Group

1 subsidiary

PHARMAQ AS parent company

Share held. Source: the Tax Administration's shareholder register, fetched 31 Jul 2026 · The whole group →

Management and ownership

§ 11 Portfolio

Holds shares in 1 company

Source: the Tax Administration's Register of Shareholders, read 31 Jul 2026 · The whole portfolio →

Management and ownership

§ 12 Network

13 connections

  • Person
  • Company

4 people link PHARMAQ AS to 10 other companies: Nils Arne Grønlie 7, Bernt Martinsen 1, Børre Furulund 2 and Ben Backmann 1.

Source: the Brønnøysund Register Centre, read 22 Oct 2026 · Explore the network →

Events and registers

§ 13 Events

38 since 2015

Events per year

20152026

  • Notices69
  • Register changes9
  • Owners in and out1

Since 2015: 69 announcements, 9 register changes and 0 new and 1 former owners. Most happened in 2015 and 2026.

Source: the announcements of the Brønnøysund Register Centre, the Tax Administration's Register of Shareholders, Doffin, TED and NAV, read 2 Nov 2026. Register changes are Intelligo's own observations. · All 38 events →

Events and registers

§ 14 Notices

69, latest 30 Jul 2026

  • Godkjente årsregnskap
  • Vedtektsdato
  • Godkjente årsregnskap

Source: The Brønnøysund Register Centre's announcements ↗, read 2 Nov 2026 · All 69 →

Events and registers

§ 15 Charges

Not fetched yet

Events and registers

§ 16 Other registers

Found in 3 of 7

  • The Central Coordinating RegisterRegistered 24 Jun 2004
  • VATRegistered
  • The Register of Business EnterprisesRegistered 24 Jun 2004
  • The Cleaning RegisterNot registered
  • The Register of Staffing AgenciesNot registered
  • Smiley scheme, the Norwegian Food Safety AuthorityNot registered
  • The Financial Supervisory Authority's licence registerNot registered

Purpose: Produksjon og salg av veterinærfarmasøytiske produkter, handel, ervervelse og drift av faste eiendommer og utnyttelse av naturforekomster, finansieringsvirksomhet, samt annen virksomhet i forbindelse med slike formål. Selskapet kan ved aksjetegning eller på annen måte, herunder ved långivning, interessere seg i andre foretagender med samme eller lignende formål.

Source: the Brønnøysund Register Centre, the Labour Inspection Authority, the Food Safety Authority and the Financial Supervisory Authority, each on its own, fetched 15 Nov 2026

Market

§ 17 Tenders

None registered

No tenders recorded.No public tenders won, lost or announced, in Doffin or TED. Checked 15 Nov 2026.

Market

§ 18 Vacancies

None registered

No vacancies.No open ads at NAV. Checked 15 Nov 2026.

Market

§ 19 Competitors

Industry code 21.200

The companies most like it:

Compare them

The selection is Intelligo's, not stated by the source: companies met in tenders and winners of tenders of the same kind, otherwise the same industry code, nearest in place and size. Source: the Brønnøysund Register Centre, Doffin and TED, fetched 15 Nov 2026 · All competitors → · Largest in the industry →

Last

§ 20 Questions and answers

6 questions

  • Who is the chief executive of PHARMAQ AS?
    Bernt Martinsen, since 2021. § 07
  • Who owns PHARMAQ AS?
    1 shareholder. It is PHARMAQ HOLDING AS with 100.0%. § 09
  • What was the revenue in 2025?
    NOK 2.6bn in the company. § 06
  • Who is the auditor?
    KPMG AS, from 24 Jun 2004. § 07
  • Where is PHARMAQ AS based?
    Skogmo Industriområde, Industrivegen 50, 7863 Overhalla.
  • When was PHARMAQ AS founded?
    27 May 2004, registered in the Register of Business Enterprises 24 Jun 2004. § 16

The answers come from the sections linked to, with their sources.

01Latest changesOverviewContentsClose